H1B11-12

N/A

Report date: 2024/03/11 17:41:30

Base Information

Drug NameH1B11-12
Drug Alias NameH1B11-12h1B11-12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGranulocyte colony-stimulating factor blockers
TargetsGranulocyte colony-stimulating factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesME Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesME Therapeutics Holdings Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A